Related Experiment Video
Updated: Jun 7, 2026

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
Published on: December 9, 2015
Flexible Cure Rate Modeling Under Latent Activation Schemes.
Freda Cooner1, Sudipto Banerjee, Bradley P Carlin
1Division of Biostatistics, Office of Surveillance and Biometrics, Center for Devices and Radiological Health, Food and Drug Administration.
This study introduces a unifying class of cure rate models for analyzing patient survival data. The new framework accounts for cured patients and distinguishes underlying mechanisms of relapse and cure.
Area of Science:
- Biostatistics
- Medical Statistics
- Survival Analysis
Background:
- Modern medical advancements lead to more cured patients in survival datasets.
- Cure rate models, including Berkson and Gage (BG type) and Yakovlev, Chen, Ibrahim, and Sinha (YCIS type), address this phenomenon.
- Bayesian hierarchical cure models are a recent area of interest, prompting research into model relationships.
Purpose of the Study:
- To propose a unifying class of cure rate models.
- To facilitate flexible hierarchical model-building.
- To include existing BG and YCIS models as special cases within a unified framework.
Main Methods:
- Development of a unifying class of cure rate models.
- Incorporation of Bayesian hierarchical modeling.
- Discussion of regressing on the cure fraction and posterior distribution propriety.
- Application to simulation studies and real-world cancer datasets (melanoma, breast cancer).
Main Results:
- The proposed unifying class encompasses both BG and YCIS models.
- The framework allows for robust modeling by addressing uncertainty in cure mechanisms.
- The model effectively distinguishes between underlying mechanisms of relapse and cure.
- Demonstrated utility through simulation and analysis of melanoma and breast cancer data.
Conclusions:
- The proposed unifying cure rate model framework offers a flexible and robust approach to survival data analysis.
- This unified model accounts for patient cure and elucidates mechanisms of relapse and cure.
- The framework is validated through simulations and real-world cancer datasets, showing its practical applicability.
Related Concept Videos
Curing Methods
Pharmacodynamic Models: Additive and Proportional Drug Effect Model
Pharmacodynamic Models: Logarithmic Concentration–Effect Model
Clearance Models: Noncompartmental Models
The noncompartmental approach capitalizes on extensive sampling data, correlating the volume of distribution to systemic exposure and the administered dosage. This method enables...
Pharmacodynamic Models: Overview
Pharmacodynamic Models: Direct Effect Model and Indirect Response Model
